Trial Profile

Effectiveness of intracoronary adenosine administration compared to placebo on myocardial perfusion in patients undergoing primary PCI

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 30 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 May 2021 Results (N=4480) of Bayesian analysis of randomized clinical trials (RCTs) to assess the role of genotype-guided P2Y12 inhibitor therapy after PCI using data from TAILOR-PCI trial) and 2) informative priors (derived from ADAPT, POPular Genetics, IAC-PCI, PHARMCLO RCTs presented at the 70th Annual Scientific Session of the American College of Cardiology
01 Aug 2009 Results published in Circulation: Cardiovascular Interventions.
31 Mar 2009 Results presented at the 58th Annual Scientific Session of the American College of Cardiology (ACC-2009).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com